PLIVA 482 (Theophylline extended-release 200 mg)

Pill imprint PLIVA 482 has been identified as Theophylline extended-release 200 mg.

Theophylline is used in the treatment of asthma, acute; apnea of prematurity; asthma, maintenance and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for PLIVA 482 (Theophylline extended-release 200 mg)

Theophylline extended-release 200 mg PLIVA 482  Front
Theophylline extended-release 200 mg PLIVA 482  Back
Theophylline extended-release 200 mg PLIVA 482
Theophylline extended-release
Imprint:
PLIVA 482
Strength:
200 mg
Color:
White
Size:
12.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Methylxanthines
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pliva Inc.
National Drug Code (NDC):
50111-0482
Inactive Ingredients:
hypromellose 2208 (100 mPa.s)
hypromellose 2208 (100000 mPa.s)
lactose anhydrous
magnesium stearate
povidone

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)